184 related articles for article (PubMed ID: 679013)
1. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
Saavedra JM; Setler PE; Kebabian JW
Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
[TBL] [Abstract][Full Text] [Related]
2. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
Gale K; Guidotti A; Costa E
Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
4. Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum.
Spano PF; Trabucchi M; Di Chiara G
Science; 1977 Jun; 196(4296):1343-5. PubMed ID: 17159
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites.
Kebabian JW; Saavedra JM
Science; 1976 Aug; 193(4254):683-5. PubMed ID: 181842
[TBL] [Abstract][Full Text] [Related]
6. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
8. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
Hefti F; Melamed E; Wurtman RJ
Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
[TBL] [Abstract][Full Text] [Related]
9. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways.
Ribak CE; Vaughn JE; Roberts E
Brain Res; 1980 Jun; 192(2):413-20. PubMed ID: 7378797
[TBL] [Abstract][Full Text] [Related]
10. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain.
Lindefors N; Brene S; Herrera-Marschitz M; Persson H
Exp Brain Res; 1989; 77(3):611-20. PubMed ID: 2572447
[TBL] [Abstract][Full Text] [Related]
11. A striatal source of glutamic acid decarboxylase activity in the substantia nigra.
Nagy JI; Fibiger HC
Brain Res; 1980 Apr; 187(1):237-42. PubMed ID: 7357470
[No Abstract] [Full Text] [Related]
12. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
[TBL] [Abstract][Full Text] [Related]
13. 6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors.
Morelli M; Carboni E; Devoto S; Di Chiara G
Eur J Pharmacol; 1987 Aug; 140(1):99-104. PubMed ID: 3113987
[TBL] [Abstract][Full Text] [Related]
14. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
Sanderson P; Mavoungou R; Albe-Fessard D
Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Brain Res; 1979 Nov; 176(2):273-84. PubMed ID: 40667
[TBL] [Abstract][Full Text] [Related]
16. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
Greenfield SA; Grünewald RA; Foley P; Shaw SG
J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
[TBL] [Abstract][Full Text] [Related]
17. Evidence concerning the anatomical location of the dopamine stimulated adenylate cyclase in the substantia nigra.
Phillipson OT; Emson PC; Horn AS; Jessell T
Brain Res; 1977 Nov; 136(1):45-58. PubMed ID: 22389
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.
Schwarcz R; Coyle JT
Life Sci; 1977 Feb; 20(3):431-6. PubMed ID: 14287
[No Abstract] [Full Text] [Related]
19. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
[TBL] [Abstract][Full Text] [Related]
20. The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway.
Kizer JS; Palkovits M; Brownstein MJ
Brain Res; 1976 May; 108(2):363-70. PubMed ID: 1276901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
